The honest answer is that it depends on you, and that is not a dodge
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg for initiation (not for glycemic control)
3000mah battery x 30C = 90,000mA = 90 Amps maximum continuous output So it's interesting to see from above that increase Capacity has a similar effect to sticking with the same size and increase C-rating
10.1002/(SICI)1097-4547(20000215)59:4 3.0.CO;2-9 Summary Keywords zebrafish, hair cell protection, hearing loss, aminoglycosides, hepatocyte growth factor, lateral line Citation Uribe PM, Kawas LH, Harding JW and Coffin AB (2015) Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure
Long-term effects of chronic GHS-R1a activation on cancer risk (GH and IGF-1 are growth factors), glucose metabolism (GH antagonizes insulin), and joint health are unknown